Flow - FLOW

Global X Funds Global X U.S. Cash Flow Kings 100 ETF (ARCA: FLOW)

Ultime notizie per Global X Funds Global X U.S. Cash Flow Kings 100 ETF (ARCA:FLOW)

SPX FLOW

Energy

Consumer Cyclical

Healthcare

Basic Materials

Technology

Industrials

Consumer Defensive

Communication Services

Utilities

Real Estate

The Fund invests at least 80 percent of its net assets, plus the amount of any borrowings for investment purposes (if any), in the securities of the Global X U.S. Cash Flow Kings 100 Index (the Underlying Index). The Fund's 80 percent investment policy is non-fundamental and requires 60 days prior written notice to shareholders before it can be changed. The Underlying Index is owned and was developed by Global X Management Company LLC (the Index Provider), an affiliate of the Fund and the Fund's investment adviser (the Adviser). The Underlying Index is administered and calculated by Mirae Asset Global Indices Pvt. Ltd. (the Index Administrator), an affiliate of the Index Provider. The Underlying Index is designed to provide exposure to large- and mid-capitalization U.S. equity securities that exhibit high free cash flow yields relative to the eligible universe of companies, as determined by the Index Administrator. Generally speaking, free cash flow is the cash a company generates after accounting for operating expenses and capital expenditures, and free cash flow yield is a financial ratio comparing the free cash flow per share a company earns against its enterprise value per share. When a company has high free cash flow yield, this indicates that the company is generating a surplus of cash, which can be utilized for paying dividends, repaying debts, buying back shares and/or investing in growth opportunities. While free cash flow yield can be a useful metric for evaluating a company, there is no guarantee that companies with high free cash flow yields will continue to maintain high free cash flow yields in the future, or that these companies will outperform companies with lower free cash flow yields.

3m Co.

Warner Bros. Discovery, Inc

Lennar Corp.

Bristol-Myers Squibb Co.

Cheniere Energy Inc

Gilead Sciences Inc

Altria Group Inc

Exxon Mobil Corp.

Valero Energy Corp

Diamondback Energy

Global X US Cash Flow Kings 100 ETF

Global X Funds Global X U.S. Cash Flow Kings 100 ETF

Flow - United States Dollar

FLOWSERVE ORD

FLOW BEVERAGE CRP SUB VTG by Flow Beverage Corp.

Flow Beverage Corp

Flow Capital Corp

Flow Traders Ltd

FLOWER ONE HOLDINGS INC by Flower One Holdings Inc.

Flower One Holdings Inc

FLOWERKIST SKIN CARE CSMT by Flowerkist Skin Care & Cosmetics, Inc.

Flowerkist Skin Care & Cosmetics Inc

Flowers Foods Inc

FLOWERY GOLD MNS OF NEV by Flowery Gold Mines Co. of Nevada

Flowery Gold Mines Co

FLOWING CLOUD TECHNOLOGY by FLOWING CLOUD TECHNOLOGY LTD.

Flowing Cloud Technology Ltd

Flowserve Corp

<ul>
<li>Gogo Inc&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gogo#NASDAQ">GOGO</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/22/04/n26490270/gogo-set-to-join-s-p-smallcap-600" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">would replace</a>&nbsp;SPX FLOW Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/flow#NYSE">FLOW</a>) in the S&amp;P SmallCap 600 effective before trading on April 8.&nbsp;</li>
<li>Lone Star Funds acquired SPX Flow. The transaction closed on April 5.</li>
<li>Gogo is an in-flight connectivity system and service provider.</li>
<li>Gogo&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/news/earnings/22/03/25960011/gogo-beats-q4-backed-by-business-aviation-connectivity-avance-platform" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">beat Q4 consensus</a>&nbsp;clocking 19% revenue growth in Q4 FY21.</li>
<li>Service revenue grew 22% Y/Y to $69.3 million. Equipment revenue rose 11% Y/Y to $23 million.</li>
<li>&quot;Demand for connectivity in business aviation, combined with the excellent performance of our AVANCE platform, are driving record sales of equipment and high-margin service plans for Gogo,&quot; said Oakleigh Thorne, Chair and CEO. &quot;We remain on track for commercial deployment of our 5G ATG network in the second half of 2022, which we expect to further accelerate our growth.&quot;</li>
<li>Price Action:&nbsp;GOGO shares traded higher by 12% at $21.50 on the last check Wednesday.</li>
</ul>

News

Movers

Tech

Trading Ideas

FLOW

GOGO

Here's Why Gogo Shares Are Trading Higher Today

<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data,</a> SPX FLOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) showed a loss in earnings since Q3, totaling $13.80 million. Sales, on the other hand, increased by 1.13% to $394.00 million during Q4. SPX FLOW reached earnings of $23.60 million and sales of $389.60 million in Q3. 
<h3>Why Is ROCE Significant?</h3>
Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q4, SPX FLOW posted an ROCE of 0.01%.
Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future. 
ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows SPX FLOW is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth. 
For SPX FLOW, the positive return on capital employed ratio of 0.01% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.
<h3>Upcoming Earnings Estimate</h3>
SPX FLOW reported Q4 earnings per share at $0.77/share, which did not meet analyst predictions of $0.94/share.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

SPX FLOW Earnings Perspective: Return On Capital Employed

&nbsp;
<h3>Companies Reporting Before The Bell</h3>
&bull; IDEAYA Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million.
&bull; Citi Trends (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) is projected to report quarterly earnings at $1.12 per share on revenue of $250.54 million.
&bull; Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) is likely to report quarterly loss at $0.47 per share on revenue of $7.75 million.
&bull; SPX FLOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) is estimated to report quarterly loss at $0.17 per share on revenue of $10.88 million.
&bull; Brickell Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBI#NASDAQ">BBI</a>) is likely to report quarterly loss at $0.08 per share on revenue of $150.00 thousand.
&bull; Imara (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRA#NASDAQ">IMRA</a>) is expected to report earnings for its fourth quarter.
&bull; Gamida Cell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMDA#NASDAQ">GMDA</a>) is estimated to report earnings for its fourth quarter.
&bull; Syros Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRS#NASDAQ">SYRS</a>) is likely to report quarterly loss at $0.47 per share on revenue of $4.80 million.
&bull; Global X Guru Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GURU#NYSE">GURU</a>) is likely to report quarterly loss at $0.16 per share on revenue of $6.75 million.
&bull; ANI Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIP#NASDAQ">ANIP</a>) is estimated to report quarterly earnings at $0.74 per share on revenue of $56.30 million.
&bull; Kandi Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNDI#NASDAQ">KNDI</a>) is projected to report earnings for its fourth quarter.
&bull; Athenex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNX#NASDAQ">ATNX</a>) is projected to report quarterly loss at $0.18 per share on revenue of $40.26 million.
&bull; IT Tech Packaging (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITP#AMEX">ITP</a>) is likely to report earnings for its fourth quarter.
&bull; IHS Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHS#NYSE">IHS</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $398.75 million.
&bull; Sovos Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOVO#NASDAQ">SOVO</a>) is expected to report quarterly earnings at $0.11 per share on revenue of $183.87 million.
&bull; Sophia Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOPH#NASDAQ">SOPH</a>) is expected to report quarterly loss at $0.36 per share on revenue of $11.20 million.
&bull; Dole (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOLE#NYSE">DOLE</a>) is likely to report quarterly earnings at $0.10 per share on revenue of $2.23 billion.
&bull; Janus Intl Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBI#NYSE">JBI</a>) is estimated to report quarterly earnings at $0.08 per share on revenue of $213.75 million.
&bull; Katapult Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPLT#NASDAQ">KPLT</a>) is expected to report quarterly loss at $0.06 per share on revenue of $72.18 million.
&bull; FTC Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTCI#NASDAQ">FTCI</a>) is projected to report quarterly loss at $0.13 per share on revenue of $72.58 million.
&bull; Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRP#NYSE">NRP</a>) is expected to report earnings for its fourth quarter.
&bull; Kamada (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KMDA#NASDAQ">KMDA</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $25.63 million.
&bull; CooTek (Cayman) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTK#NYSE">CTK</a>) is expected to report quarterly loss at $0.01 per share on revenue of $49.60 million.
&nbsp;
<h3>Companies Reporting After The Bell</h3>
&bull; Aspen Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPU#NASDAQ">ASPU</a>) is expected to report quarterly loss at $0.09 per share on revenue of $18.79 million.
&bull; Bird Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRDS#NYSE">BRDS</a>) is projected to report quarterly loss at $0.34 per share on revenue of $50.78 million.
&bull; HireQuest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQI#NASDAQ">HQI</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $5.67 million.
&bull; Opiant Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPNT#NASDAQ">OPNT</a>) is expected to report quarterly loss at $0.01 per share on revenue of $13.26 million.
&bull; LexinFintech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LX#NASDAQ">LX</a>) is projected to report earnings for its fourth quarter.
&bull; Lument Finance Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LFT#NYSE">LFT</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $6.02 million.
&bull; HyreCar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYRE#NASDAQ">HYRE</a>) is expected to report quarterly loss at $0.27 per share on revenue of $10.32 million.
&bull; Surgalign Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRGA#NASDAQ">SRGA</a>) is estimated to report quarterly loss at $0.11 per share on revenue of $20.71 million.
&bull; GoHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOCO#NASDAQ">GOCO</a>) is likely to report quarterly earnings at $0.15 per share on revenue of $527.64 million.
&bull; Zedge (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZDGE#AMEX">ZDGE</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $6.21 million.
&bull; Performant Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFMT#NASDAQ">PFMT</a>) is projected to report quarterly loss at $0.02 per share on revenue of $29.81 million.
&bull; Cherry Hill Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHMI#NYSE">CHMI</a>) is estimated to report quarterly earnings at $0.28 per share on revenue of $6.22 million.
&bull; Park-Ohio Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PKOH#NASDAQ">PKOH</a>) is projected to report quarterly loss at $0.12 per share on revenue of $364.23 million.
&bull; Champions Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSBR#NASDAQ">CSBR</a>) is expected to report quarterly earnings at $0.02 per share on revenue of $12.47 million.
&bull; JOYY (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YY#NASDAQ">YY</a>) is estimated to report quarterly earnings at $0.36 per share on revenue of $652.43 million.
&bull; Clipper Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLPR#NYSE">CLPR</a>) is likely to report quarterly loss at $0.07 per share on revenue of $31.31 million.
&bull; Seritage Growth Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRG#NYSE">SRG</a>) is projected to report earnings for its fourth quarter.
&bull; Eastman Kodak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KODK#NYSE">KODK</a>) is projected to report earnings for its fourth quarter.
&bull; Ryan Specialty Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAN#NYSE">RYAN</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $378.80 million.
&bull; European Wax Center (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>) is estimated to report quarterly earnings at $0.11 per share on revenue of $44.76 million.
&bull; Alpha Teknova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKNO#NASDAQ">TKNO</a>) is projected to report quarterly loss at $0.17 per share on revenue of $8.44 million.
&bull; SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) is expected to report quarterly loss at $0.18 per share on revenue of $60.68 million.
&bull; Markforged Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKFG#NYSE">MKFG</a>) is likely to report quarterly loss at $0.08 per share on revenue of $24.51 million.
&bull; Angel Oak Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOMR#NYSE">AOMR</a>) is estimated to report quarterly earnings at $0.39 per share on revenue of $15.43 million.
&bull; Talis Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLIS#NASDAQ">TLIS</a>) is likely to report quarterly loss at $1.28 per share on revenue of $1.33 million.
&bull; Volt Information Sciences (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VOLT#AMEX">VOLT</a>) is expected to report quarterly loss at $0.13 per share on revenue of $225.50 million.
&bull; Smartsheet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $151.66 million.
&bull; CarLotz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOTZ#NASDAQ">LOTZ</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $72.95 million.
&bull; Shift Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFT#NASDAQ">SFT</a>) is likely to report quarterly loss at $0.61 per share on revenue of $185.86 million.
&bull; Atlas Technical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATCX#NASDAQ">ATCX</a>) is estimated to report quarterly earnings at $0.12 per share on revenue of $140.12 million.
&bull; TRACON Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) is estimated to report quarterly loss at $0.35 per share on revenue of $60.00 thousand.
&bull; Northwest Pipe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWPX#NASDAQ">NWPX</a>) is projected to report quarterly earnings at $0.56 per share on revenue of $92.00 million.
&bull; Athersys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHX#NASDAQ">ATHX</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $40.00 thousand.
&bull; Caleres (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAL#NYSE">CAL</a>) is projected to report quarterly earnings at $0.67 per share on revenue of $677.21 million.
&bull; FutureFuel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FF#NYSE">FF</a>) is likely to report earnings for its fourth quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

Pre-Market Outlook

Markets

ANIP

AOMR

ASPU

ATCX

ATHX

ATNX

BRDS

CHMI

CLPR

CSBR

CTRN

DOLE

DTIL

EWCZ

FTCI

GMDA

GOCO

GURU

HYRE

IDYA

IMRA

KMDA

KNDI

KODK

KPLT

LOTZ

MKFG

NWPX

OPNT

PFMT

PKOH

RYAN

SMAR

SOPH

SOVO

SRGA

SYRS

TCON

TKNO

TLIS

VOLT

ZDGE

Earnings Scheduled For March 15, 2022

Penny Stocks

Health Care

Small Cap

General

ACBI

BBBY

CCMP

CPLG

ENTG

FRME

FTSI

FULT

LEVL

LITE

MCFE

MSFT

NCMGY

NUAN

PAQC

PBCT

PBIP

REGI

RTOKY

SPGI

STFC

WHLR

ZGNX

Merger Arbitrage Mondays - Healthcare Trust Of America To Combine With Healthcare Realty Trust

SPX FLOW, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) (the &quot;Company&quot;), a leading provider of process solutions for the nutrition, health and industrial markets, announced today that its stockholders approved the proposed merger of the Company and Redwood Star Merger Sub, Inc. (&quot;Merger Sub&quot;), a Delaware corporation and a wholly owned subsidiary of LSF11 Redwood Acquisitions, LLC (&quot;Parent&quot;), a Delaware limited liability company and an affiliate of Lone Star Funds (&quot;Lone Star&quot;), a leading private equity firm, pursuant to the Agreement and Plan of Merger, dated as of December 12, 2021 (the &quot;Merger Agreement&quot;), by and among the Company, Merger Sub and Parent (the &quot;Merger&quot;).
Subject to the satisfaction or waiver of the remaining conditions to closing, the Merger is expected to close in the second quarter of 2022.
&quot;We thank our stockholders for their strong support of this transaction with Lone Star, which will provide compelling, immediate and certain stockholder value and position SPX FLOW to continue delivering reliable outcomes for our customers,&quot; said Marc Michael, SPX FLOW President and Chief Executive Officer. &quot;With this significant milestone behind us, we look forward to completing the transaction with Lone Star.&quot;

Stockholders Of SPX FLOW Approve Merger With An Affiliate Of Lone Star Funds

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro data</a> SPX FLOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) posted a 41.53% decrease in earnings from Q3. Sales, however, increased by 1.13% over the previous quarter to $394.00 million. Despite the increase in sales this quarter, the decrease in earnings may suggest SPX FLOW is not utilizing their capital as effectively as possible. In Q3, SPX FLOW earned $23.60 million and total sales reached $389.60 million. 
<h3>What Is Return On Capital Employed?</h3>
Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q4, SPX FLOW posted an ROCE of 0.01%.
Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future. 
ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows SPX FLOW is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth. 
For SPX FLOW, the positive return on capital employed ratio of 0.01% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.
<h3>Upcoming Earnings Estimate</h3>
SPX FLOW reported Q4 earnings per share at $0.77/share, which did not meet analyst predictions of $0.94/share.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SPX FLOW's Return On Capital Employed Insights

&nbsp;
SPX FLOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) reported its Q4 earnings results on Wednesday, February 16, 2022 at 06:30 AM.
Here&#39;s what investors need to know about the announcement.
<h3>Earnings</h3>
SPX FLOW missed estimated earnings by 18.09%, reporting an EPS of $0.77 versus an estimate of $0.94.
Revenue was up $2.10 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.09, which was followed by a 1.13% increase in the share price the next day.
Here&#39;s a look at SPX FLOW&#39;s past performance:
&nbsp;
<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2021</th>
<th>Q2 2021</th>
<th>Q1 2021</th>
<th>Q4 2020</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.70</td>
<td>0.59</td>
<td>0.35</td>
<td>0.37</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.79</td>
<td>0.63</td>
<td>0.61</td>
<td>0.56</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>391.92M</td>
<td>369.88M</td>
<td>341.85M</td>
<td>350.16M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>389.60M</td>
<td>381.60M</td>
<td>363.80M</td>
<td>396.10M</td>
</tr>
</tbody>
</table>
To track all upcoming earnings announcements, click to use <a href="https://www.benzinga.com/calendars/earnings">Benzinga Earnings Calendar</a>.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

SPX FLOW: Q4 Earnings Insights

SPX FLOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) reported quarterly earnings of $0.77 per share. This is a 37.5 percent increase over earnings of $0.56 per share from the same period last year. The company reported $394.00 million in sales this quarter. This is a 0.53 percent decrease over sales of $396.10 million the same period last year.

SPX FLOW Q4 EPS From Continuing Operations $0.77 Up From $0.56 YoY, Sales $394.00M Down From $396.10M YoY

<h3>Upgrades</h3>
For Enova International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENVA#NYSE">ENVA</a>), Maxim Group upgraded the previous rating of Hold to Buy. For the fourth quarter, Enova International had an EPS of $1.61, compared to year-ago quarter EPS of $2.39. The current stock performance of Enova International shows a 52-week-high of $44.43 and a 52-week-low of $23.88. Moreover, at the end of the last trading period, the closing price was at $41.22. 
Argus Research upgraded the previous rating for Nasdaq Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) from Hold to Buy. For the fourth quarter, Nasdaq had an EPS of $1.93, compared to year-ago quarter EPS of $1.60. The current stock performance of Nasdaq shows a 52-week-high of $214.96 and a 52-week-low of $135.57. Moreover, at the end of the last trading period, the closing price was at $178.62. 
Argus Research upgraded the previous rating for The Hershey Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) from Hold to Buy. Hershey earned $1.69 in the fourth quarter, compared to $1.49 in the year-ago quarter. The stock has a 52-week-high of $206.16 and a 52-week-low of $143.58. At the end of the last trading period, Hershey closed at $202.78. 
For Power Integrations Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWI#NASDAQ">POWI</a>), Susquehanna upgraded the previous rating of Neutral to Positive. For the fourth quarter, Power Integrations had an EPS of $0.83, compared to year-ago quarter EPS of $0.60. At the moment, the stock has a 52-week-high of $110.66 and a 52-week-low of $72.50. Power Integrations closed at $83.11 at the end of the last trading period. 
Citigroup upgraded the previous rating for Apollo Investment Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AINV#NASDAQ">AINV</a>) from Sell to Neutral. Apollo Investment earned $0.35 in the third quarter, compared to $0.43 in the year-ago quarter. The stock has a 52-week-high of $15.27 and a 52-week-low of $11.75. At the end of the last trading period, Apollo Investment closed at $13.46. 
RBC Capital upgraded the previous rating for Continental Resources Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLR#NYSE">CLR</a>) from Sector Perform to Outperform. In the third quarter, Continental Resources showed an EPS of $1.20, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $59.82 and a 52-week-low of $20.04. Continental Resources closed at $57.25 at the end of the last trading period. 
For Black Hills Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKH#NYSE">BKH</a>), Mizuho upgraded the previous rating of Neutral to Buy. In the third quarter, Black Hills showed an EPS of $0.70, compared to $0.58 from the year-ago quarter. The stock has a 52-week-high of $72.78 and a 52-week-low of $58.42. At the end of the last trading period, Black Hills closed at $64.96. 
According to UBS, the prior rating for American Water Works Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWK#NYSE">AWK</a>) was changed from Sell to Neutral. In the third quarter, American Water Works Co showed an EPS of $1.53, compared to $1.46 from the year-ago quarter. The current stock performance of American Water Works Co shows a 52-week-high of $189.65 and a 52-week-low of $131.01. Moreover, at the end of the last trading period, the closing price was at $155.50. 
For Snowflake Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Snowflake showed an EPS of $0.04, compared to $0.28 from the year-ago quarter. At the moment, the stock has a 52-week-high of $405.00 and a 52-week-low of $184.71. Snowflake closed at $275.72 at the end of the last trading period. 
According to JP Morgan, the prior rating for Minerals Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTX#NYSE">MTX</a>) was changed from Neutral to Overweight. Minerals Technologies earned $1.25 in the fourth quarter, compared to $1.08 in the year-ago quarter. The stock has a 52-week-high of $88.62 and a 52-week-low of $64.05. At the end of the last trading period, Minerals Technologies closed at $66.00. 
Oppenheimer upgraded the previous rating for Intellia Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) from Perform to Outperform. Intellia Therapeutics earned $0.97 in the third quarter, compared to $0.47 in the year-ago quarter. At the moment, the stock has a 52-week-high of $202.73 and a 52-week-low of $43.86. Intellia Therapeutics closed at $95.96 at the end of the last trading period. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
<h3>Downgrades</h3>
Scotiabank downgraded the previous rating for Exelon Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>) from Sector Outperform to Sector Perform. For the third quarter, Exelon had an EPS of $1.09, compared to year-ago quarter EPS of $1.04. The current stock performance of Exelon shows a 52-week-high of $58.21 and a 52-week-low of $38.35. Moreover, at the end of the last trading period, the closing price was at $43.52. 
Cowen &amp; Co. downgraded the previous rating for FIGS Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIGS#NYSE">FIGS</a>) from Outperform to Market Perform. The current stock performance of FIGS shows a 52-week-high of $50.40 and a 52-week-low of $19.50. Moreover, at the end of the last trading period, the closing price was at $21.49. 
According to B of A Securities, the prior rating for Air Products &amp; Chemicals Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) was changed from Buy to Neutral. Air Products &amp; Chemicals earned $2.52 in the first quarter, compared to $2.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $316.39 and a 52-week-low of $245.75. Air Products &amp; Chemicals closed at $263.08 at the end of the last trading period. 
According to Wells Fargo, the prior rating for NuStar Energy LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NS#NYSE">NS</a>) was changed from Overweight to Equal-Weight. In the fourth quarter, NuStar Energy showed an EPS of $0.14, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $20.73 and a 52-week-low of $13.53. NuStar Energy closed at $17.85 at the end of the last trading period. 
JP Morgan downgraded the previous rating for NOV Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) from Overweight to Neutral. In the fourth quarter, NOV showed an EPS of $0.10, compared to $0.29 from the year-ago quarter. The stock has a 52-week-high of $18.02 and a 52-week-low of $11.46. At the end of the last trading period, NOV closed at $16.21. 
BMO Capital downgraded the previous rating for Ballard Power Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDP#NASDAQ">BLDP</a>) from Outperform to Market Perform. In the third quarter, Ballard Power Systems showed an EPS of $0.10, compared to $0.05 from the year-ago quarter. The current stock performance of Ballard Power Systems shows a 52-week-high of $42.28 and a 52-week-low of $8.57. Moreover, at the end of the last trading period, the closing price was at $9.73. 
According to RBC Capital, the prior rating for Cigna Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) was changed from Outperform to Sector Perform. For the fourth quarter, Cigna had an EPS of $4.77, compared to year-ago quarter EPS of $3.51. The stock has a 52-week-high of $272.81 and a 52-week-low of $191.74. At the end of the last trading period, Cigna closed at $221.37. 
Goldman Sachs downgraded the previous rating for Diversey Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSEY#NASDAQ">DSEY</a>) from Buy to Neutral. At the moment, the stock has a 52-week-high of $18.61 and a 52-week-low of $9.87. Diversey Holdings closed at $10.68 at the end of the last trading period. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
<h3>Initiations</h3>
Keefe, Bruyette &amp; Woods initiated coverage on TPG Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with a Market Perform rating. The price target for TPG is set to $37.00. The current stock performance of TPG shows a 52-week-high of $35.40 and a 52-week-low of $30.12. Moreover, at the end of the last trading period, the closing price was at $33.08. 
Northland Capital Markets initiated coverage on Cyteir Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYT#NASDAQ">CYT</a>) with an Outperform rating. The price target for Cyteir Therapeutics is set to $16.00. For the third quarter, Cyteir Therapeutics had an EPS of $0.33, compared to year-ago quarter EPS of $3.44. The current stock performance of Cyteir Therapeutics shows a 52-week-high of $23.10 and a 52-week-low of $5.13. Moreover, at the end of the last trading period, the closing price was at $5.91. 
With a Buy rating, Aegis Capital initiated coverage on American Finance Trust Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFIN#NASDAQ">AFIN</a>). The price target seems to have been set at $12.00 for American Finance Trust. For the third quarter, American Finance Trust had an EPS of $0.30, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $10.69 and a 52-week-low of $7.50. At the end of the last trading period, American Finance Trust closed at $8.08. 
With a Hold rating, Jefferies initiated coverage on Ozon Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OZON#NASDAQ">OZON</a>). The price target seems to have been set at $23.00 for Ozon Holdings. The current stock performance of Ozon Holdings shows a 52-week-high of $68.77 and a 52-week-low of $15.37. Moreover, at the end of the last trading period, the closing price was at $20.26. 
For New Mountain Finance Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMFC#NASDAQ">NMFC</a>), Janney Montgomery Scott initiated coverage, by setting the current rating at Buy. The current stock performance of New Mountain Finance shows a 52-week-high of $14.11 and a 52-week-low of $11.80. Moreover, at the end of the last trading period, the closing price was at $13.40. 
With a Buy rating, Craig-Hallum initiated coverage on Zeta Global Holdings Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>). The price target seems to have been set at $14.00 for Zeta Global Holdings. At the moment, the stock has a 52-week-high of $11.14 and a 52-week-low of $5.27. Zeta Global Holdings closed at $9.88 at the end of the last trading period. 
Evercore ISI Group initiated coverage on TPG Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with an In-Line rating. The price target for TPG is set to $37.00. The current stock performance of TPG shows a 52-week-high of $35.40 and a 52-week-low of $30.12. Moreover, at the end of the last trading period, the closing price was at $33.08. 
B of A Securities initiated coverage on TPG Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with a Buy rating. The price target for TPG is set to $47.00. The stock has a 52-week-high of $35.40 and a 52-week-low of $30.12. At the end of the last trading period, TPG closed at $33.08. 
BMO Capital initiated coverage on Plymouth Industrial REIT Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLYM#NYSE">PLYM</a>) with a Market Perform rating. The price target for Plymouth Industrial REIT is set to $30.00. Plymouth Industrial REIT earned $0.31 in the third quarter, compared to $0.38 in the year-ago quarter. The current stock performance of Plymouth Industrial REIT shows a 52-week-high of $32.37 and a 52-week-low of $14.52. Moreover, at the end of the last trading period, the closing price was at $28.40. 
With a Buy rating, Needham initiated coverage on Esports Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBET#NASDAQ">EBET</a>). The price target seems to have been set at $18.00 for Esports Technologies. The stock has a 52-week-high of $54.00 and a 52-week-low of $9.33. At the end of the last trading period, Esports Technologies closed at $11.05. 
Wells Fargo initiated coverage on TPG Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with a Equal-Weight rating. The price target for TPG is set to $34.00. The stock has a 52-week-high of $35.40 and a 52-week-low of $30.12. At the end of the last trading period, TPG closed at $33.08. 
EF Hutton initiated coverage on SPX FLOW Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) with a Buy rating. The price target for SPX FLOW is set to $4.50. For the third quarter, SPX FLOW had an EPS of $0.79, compared to year-ago quarter EPS of $0.48. The stock has a 52-week-high of $88.55 and a 52-week-low of $55.25. At the end of the last trading period, SPX FLOW closed at $85.58. 
Truist Securities initiated coverage on Postal Realty Trust Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTL#NYSE">PSTL</a>) with a Hold rating. The price target for Postal Realty Trust is set to $19.00. In the third quarter, Postal Realty Trust showed an EPS of $0.27, compared to $0.24 from the year-ago quarter. The current stock performance of Postal Realty Trust shows a 52-week-high of $21.27 and a 52-week-low of $15.65. Moreover, at the end of the last trading period, the closing price was at $17.80. 
With a Buy rating, HC Wainwright &amp; Co. initiated coverage on Inozyme Pharma Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INZY#NASDAQ">INZY</a>). The price target seems to have been set at $33.00 for Inozyme Pharma. In the third quarter, Inozyme Pharma showed an EPS of $0.60, compared to $1.55 from the year-ago quarter. The stock has a 52-week-high of $23.00 and a 52-week-low of $5.33. At the end of the last trading period, Inozyme Pharma closed at $6.10. 
With an Overweight rating, Morgan Stanley initiated coverage on IVERIC bio Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISEE#NASDAQ">ISEE</a>). The price target seems to have been set at $25.00 for IVERIC bio. IVERIC bio earned $0.23 in the third quarter, compared to $0.27 in the year-ago quarter. The stock has a 52-week-high of $19.32 and a 52-week-low of $5.48. At the end of the last trading period, IVERIC bio closed at $13.90. 
With a Equal-Weight rating, Morgan Stanley initiated coverage on TPG Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>). The price target seems to have been set at $38.00 for TPG. The current stock performance of TPG shows a 52-week-high of $35.40 and a 52-week-low of $30.12. Moreover, at the end of the last trading period, the closing price was at $33.08. 
UBS initiated coverage on TPG Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with a Buy rating. The price target for TPG is set to $41.00. The stock has a 52-week-high of $35.40 and a 52-week-low of $30.12. At the end of the last trading period, TPG closed at $33.08. 
Goldman Sachs initiated coverage on Ermenegildo Zegna NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZGN#NYSE">ZGN</a>) with a Neutral rating. The price target for Ermenegildo Zegna is set to $12.00. The current stock performance of Ermenegildo Zegna shows a 52-week-high of $12.65 and a 52-week-low of $9.22. Moreover, at the end of the last trading period, the closing price was at $10.65. 
With a Neutral rating, Goldman Sachs initiated coverage on TPG Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>). The price target seems to have been set at $34.50 for TPG. The current stock performance of TPG shows a 52-week-high of $35.40 and a 52-week-low of $30.12. Moreover, at the end of the last trading period, the closing price was at $33.08. 
JP Morgan initiated coverage on Frontier Communications Parent Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FYBR#NASDAQ">FYBR</a>) with an Overweight rating. The price target for Frontier Communications is set to $40.00. The current stock performance of Frontier Communications shows a 52-week-high of $35.15 and a 52-week-low of $23.24. Moreover, at the end of the last trading period, the closing price was at $26.04. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Upgrades

Downgrades

Initiation

Intraday Update

Analyst Ratings

AFIN

AINV

BLDP

DSEY

EBET

ENVA

FIGS

FYBR

INZY

ISEE

NDAQ

NMFC

NTLA

OZON

PLYM

POWI

PSTL

SNOW

ZETA

Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2022

Barclays&nbsp;analyst Julian Mitchell adjusts price targets for several multi-industry companies.
<ul>
<li>Mitchell expects inflation to boost sales for multi-industry companies in Q4, but he sees margin pressure in the near term.&nbsp;</li>
<li>The analyst&#39;s 2022 earnings estimates are slightly above consensus, and he thinks Street numbers need to be more backend loaded.&nbsp;</li>
<li>The stronger U.S. dollar is also an &quot;emerging headwind,&quot; says Mitchell.</li>
<li>The analyst raised&nbsp;Johnson Controls International PLC&#39;s&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jci#NYSE">JCI</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/quote/JCI/analyst-ratings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">price target to $86</a>&nbsp;(an upside of 6%) from $85 and kept an Overweight rating on the shares.&nbsp;</li>
<li>The analyst lowered&nbsp;3M Co&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmm#NYSE">MMM</a>)<a class="editor-rtfLink" href="https://www.benzinga.com/quote/MMM/analyst-ratings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">&nbsp;price target to $177</a>&nbsp;(a downside of 2%) from $182 and kept an Underweight rating on the shares.&nbsp;</li>
<li>The analyst raised&nbsp;Stanley Black &amp; Decker, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/swk#NYSE">SWK</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/quote/SWK/analyst-ratings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">price target to $232</a>&nbsp;(an upside of 20%) from $231 and kept an Overweight rating on the shares.</li>
<li>The analyst raised&nbsp;SPX Flow Inc&#39;s&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/flow#NYSE">FLOW</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/quote/FLOW/analyst-ratings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">price target to $86&nbsp;</a>(a downside of 1%) from $75 and kept an Equal Weight rating on the shares.</li>
<li>The analyst raised&nbsp;Regal Rexnord Corp&#39;s&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rrx#NYSE">RRX</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/quote/RRX/analyst-ratings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">price target to $204&nbsp;</a>(an upside of 16.4%) from $200 and kept an Overweight rating on the shares.</li>
<li>The analyst raised&nbsp;Ingersoll Rand Inc&#39;s&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ir#NYSE">IR</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/quote/IR/analyst-ratings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">price target to $74&nbsp;</a>(an upside of 21.8%) from $70 and kept an Overweight rating on the shares.</li>
<li>The analyst raised&nbsp;Emerson Electric Co&#39;s&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/emr#NYSE">EMR</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/quote/EMR/analyst-ratings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">price target to $99</a>&nbsp;(an upside of 3.5%) from $98 and kept an Equal-Weight rating on the shares.</li>
<li>The analyst raised&nbsp;Dover Corp&#39;s&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dov#NYSE">DOV</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/quote/DOV/analyst-ratings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">price target to $206</a>&nbsp;(an upside of 13%) from $185 and kept an Overweight rating on the shares.</li>
<li>The analyst raised&nbsp;APi Group Corp&#39;s&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/apg#NYSE">APG</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/quote/APG/analyst-ratings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">price target to $30</a>&nbsp;(an upside of 13.7%) from $24 and kept an Overweight rating on the shares.</li>
<li>Price Action:&nbsp;JCI shares are higher by 2.27% at $81.15, MMM higher by 1.71% at $180.79, SWK higher by 3.74% at $192.87, FLOW higher by 0.50% at $86.88, RRX higher by 2.71% at $175.42, IR higher by 1.9% at $60.77, EMR higher by 4.17% at $95.59, DOV higher by 2.39% at $182.60, and APG higher by 2.49% at $26.39 on the last check Tuesday.</li>
</ul>

Analyst Color

Price Target

Reiteration

CARR

Barclays Bumps Up Price Target For Several Multi-Industry Companies

Barclays maintains SPX FLOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) with a Equal-Weight and raises the price target from $75 to $86.

Barclays Maintains Equal-Weight on SPX FLOW, Raises Price Target to $86

SPX Flow Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/flow#NYSE">FLOW</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/12/n24566081/spx-flow-to-be-acquired-by-lone-star-for-86-50-per-share-in-cash" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">agreed to be acquired</a>&nbsp;by an affiliate of Lone Star Funds in an all-cash transaction valued at $3.8 billion, including the assumption of debt.
<ul>
<li>The per-share value of $86.50 represents a premium of ~1% over the closing price on Friday. It represents a premium of nearly 40% over the company&#39;s closing stock price on July 16, 2021, the last trading day before reports about receiving an unsolicited purchase offer.</li>
<li>The company had announced in late July 2021 that its Board had authorized a&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/m-a/21/07/22152013/spx-flow-shares-gain-as-it-explores-strategic-options" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">review of strategic alternatives</a>, including a possible sale or merger.</li>
<li>Previously, the company had received and rejected an unsolicited, conditional, non-binding proposal from&nbsp;Ingersoll Rand Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ir#NYSE">IR</a>) for $85.00 per share. This followed a similar unsolicited proposal from Ingersoll Rand for $81.50 per share.</li>
<li>Upon completing the Lone Star Funds transaction, SPX Flow&nbsp;will become a privately held company, and the shares will no longer trade on NYSE. The transaction is expected to close in 1H 2022.&nbsp;</li>
<li>As a condition to the transaction, SPX Flow suspended its quarterly dividend payment, effective immediately.</li>
<li>Price Action:&nbsp;FLOW shares are trading higher by 0.14% at $85.75 during the premarket session on Monday.</li>
</ul>

SPX Flow Agrees To Be Acquired By Lone Star For $3.8B

SPX FLOW To Be Acquired By Lone Star For $86.50/Share In Cash

&nbsp;
In the current market session, SPX FLOW Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) is trading at $84.29, after a 0.1% decrease. However, over the past month, the stock went up by 8.16%, and in the past year, by 56.98%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session.
Assuming that all other factors are held constant, this could present itself as an opportunity for shareholders trying to capitalize on the higher share price. The stock is currently under from its 52 week high by 4.81%.
<img alt="Price Candles" src="https://www.benzinga.com/files/images/story/2021/1638283856_0.png" />
The P/E ratio measures the current share price to the company&#39;s earnings per share. It is used by long-term investors to analyze the company&#39;s current performance against its past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also shows that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future.
Depending on the particular phase of a business cycle, some industries will perform better than others.
Compared to the aggregate P/E ratio of 35.6 in the Machinery industry, SPX FLOW Inc. has a higher P/E ratio of 48.19. Shareholders might be inclined to think that SPX FLOW Inc. might perform better than its industry group. It&#39;s also possible that the stock is overvalued.
<img alt="Price Candles" src="https://www.benzinga.com/files/images/story/2021/1638283856_1.png" />
P/E ratio is not always a great indicator of the company&#39;s performance. Depending on the earnings makeup of a company, investors can become unable to attain key insights from trailing earnings.

Price To Earnings Ratio Insights For SPX FLOW

&nbsp;SPX FLOW, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>), a leading provider of process solutions for the nutrition, health and industrial markets, will provide its&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3372559-1&amp;h=2662174067&amp;u=https%3A%2F%2Fwww.spxflow.com%2Fsolutions%2Fthermal-processing-uht%2F&amp;a=Ultra+High+Temperature+(UHT)+technology" target="_blank">Ultra High Temperature (UHT) technology</a>&nbsp;process lines to one of the&nbsp;Middle East&#39;s&nbsp;leading dairy producers.
<a href="https://mma.prnewswire.com/media/1508392/SPX_Flow_Logo.html" target="_blank"><img alt="SPX FLOW, Inc. Logo (PRNewsfoto/SPX FLOW, Inc.)" src="https://mma.prnewswire.com/media/1508392/SPX_Flow_Logo.jpg" /></a>
The sale comes just days after SPX FLOW and SIG announced something that&#39;s unprecedented in the&nbsp;Middle East: a new Technology Center in&nbsp;Dubai&nbsp;that will stretch the value chain all the way from research and development to processing and packaging. The Technology Center will accelerate how customers test a complete delivery solution, speeding up their time to market.
The customer, a producer of long-life milk, flavored milk and feta cheese, will install two UHT process lines, as well as SPX FLOW valves, pumps, a&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3372559-1&amp;h=3936469693&amp;u=https%3A%2F%2Fwww.spxflow.com%2Fsolutions%2Fhomogenization%2F&amp;a=homogenizer" target="_blank">homogenizer</a>, a&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3372559-1&amp;h=1639892096&amp;u=https%3A%2F%2Fwww.spxflow.com%2Fsolutions%2Fmixing-blending%2F&amp;a=mixer" target="_blank">mixer</a>&nbsp;and components for&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3372559-1&amp;h=2990048929&amp;u=https%3A%2F%2Fwww.spxflow.com%2Fcapabilities%2Fplate-heat-exchanger-services%2F&amp;a=plate+heat+exchangers" target="_blank">plate heat exchangers</a>.
&quot;This is exactly what we envisioned would happen with the Technology Center,&quot; said&nbsp;Gerard Lang,&nbsp;SPX FLOW&#39;s vice president of&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3372559-1&amp;h=865688005&amp;u=https%3A%2F%2Fwww.spxflow.com%2Fabout%2Four-company%2F&amp;a=Nutrition+%26+Health+Systems" target="_blank">Nutrition &amp; Health Systems</a>. &quot;This new collaboration makes us a one-stop provider for a complete process solution, and companies in the&nbsp;Middle East&nbsp;have been waiting a long time for this.&quot;
SPX FLOW helped pioneer UHT development during the 1950s and 1960s. Today, the company offers a large choice of technology, ranging from low cost &quot;express&quot; systems to customized solutions that meet exact processing needs and specific product qualities.
UHT processes many products, such as dairy, grain, fruit, nuts and liquids, including yogurt, sauces, juices and baby food. At the Technology Center, SPX FLOW will test products, finding the right balance between optimal temperature and total processing time. This extends product shelf life while retaining the taste, texture and depth consumers expect.
One of SPX FLOW&#39;s most popular UHT technologies is&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3372559-1&amp;h=2075289967&amp;u=https%3A%2F%2Fwww.spxflow.com%2Fapv%2Fproducts%2Finfusion-uht-sdh%2F&amp;a=InfusionPlus" target="_blank">InfusionPlus</a>. It holds products at high temperatures for only a short time. The UHT reaches 157&deg;C, and the holding time is less than 0.1 seconds.
For many competitors, the holding time often takes at least 1 second, which means the product cannot sustain temperatures as high as InfusionPlus. SPX FLOW has done trials with its own equipment, and even just an extra tenth of a second meant people could taste the caramelisation. It&#39;s called the Maillard reaction, and it changes the color of the milk while also making it taste boiled.
&quot;Customers are quickly making reservations at the Technology Center to benchmark their recipes to see about taste and color,&quot; Lang said. &quot;We expect in the next few months, the Technology Center will be fully booked.&quot;
To learn more about SPX FLOW, please visit&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3372559-1&amp;h=1212437450&amp;u=http%3A%2F%2Fwww.spxflow.com%2F&amp;a=our+website" target="_blank">our website</a>.

Contracts

SPX FLOW Says Co Will Provide Ultra High Temperature Process Lines To One Of Middle East's Leading Dairy Producers; Terms Not Disclosed

RBC Capital analyst Deane Dray maintains SPX FLOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) with a Sector Perform and raises the price target from $77 to $79.

RBC Capital Maintains Sector Perform on SPX FLOW, Raises Price Target to $79

SPX FLOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.70 by 12.86 percent. This is a 64.58 percent increase over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $389.60 million which missed the analyst consensus estimate of $391.92 million by 0.59 percent. This is a 9.16 percent increase over sales of $356.90 million the same period last year.

SPX FLOW Q3 Adj. EPS $0.79 Beats $0.70 Estimate, Sales $389.60M Miss $391.92M Estimate

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro,</a> during Q2, SPX FLOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) earned $28.90 million, a 11.58% increase from the preceding quarter. SPX FLOW also posted a total of $381.60 million in sales, a 4.89% increase since Q1. In Q1, SPX FLOW earned $25.90 million, and total sales reached $363.80 million. 
<h3>What Is ROIC?</h3>
Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business. Changes in earnings and sales indicate shifts in a company's ROIC. A higher ROIC is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROIC suggests the opposite. In Q2, SPX FLOW posted an ROIC of 2.28%.
Keep in mind, while ROIC is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future. 
Earnings data without context is not clear and can difficult to base trading decisions on. Return on Invested Capital (ROIC) helps to filter signal from noise by measuring yearly pre-tax profit relative to invested capital by a business. Generally, a higher ROIC suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q2, SPX FLOW posted an ROIC of 2.28%.
It is important to keep in mind that ROIC evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but does not account for factors that could affect earnings and sales in the near future. 
For SPX FLOW, the positive return on invested capital ratio of 2.28% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.
<h3>Upcoming Earnings Estimate</h3>
SPX FLOW reported Q2 earnings per share at $0.63/share, which beat analyst predictions of $0.59/share.

How Good Are SPX FLOW's Earnings? | Return On Invested Capital

&nbsp;
Shares of SPX FLOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) were unchanged after the company reported Q2 results.
<h2>Quarterly Results</h2>
Earnings per share rose 186.36% over the past year to $0.63, which beat the estimate of $0.59.
Revenue of $381,600,000 rose by 23.86% year over year, which beat the estimate of $369,880,000.
<h2>Outlook</h2>
Earnings guidance hasn&#39;t been issued by the company for now.
SPX FLOW hasn&#39;t issued any revenue guidance for the time being.
<h2>How To Listen To The Conference Call</h2>
Date: Aug 04, 2021
Time: 09:00 AM
ET Webcast URL: <a href="https://www.webcaster4.com/Webcast/Page/2607/42122" title="https://www.webcaster4.com/Webcast/Page/2607/42122">https://www.webcaster4.com/Webcast/Page/2607/42122</a>
<h2>Technicals</h2>
52-week high: $86.17
52-week low: $39.83
Price action over last quarter: Up 20.37%
<h2>Company Profile</h2>
SPX Flow offers engineering solutions in two segments: food and beverage segment and industrial segment. The food and beverage segment provides technology for dairy consumption, expansion to emerging markets, productivity improvements, and food safety. The industrial segment services the chemical, mining, air, and water treatment industries. Both segments sell products such as pumps, blenders, separators, air dryers, heat exchangers, and hydraulic tools. SPX Flow operates worldwide, with sales in the Americas, Europe, Africa, and Asia.

SPX FLOW: Q2 Earnings Insights

SPX FLOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOW#NYSE">FLOW</a>) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.59 by 54.24 percent. This is a 22.73 percent increase over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $381.60 million which beat the analyst consensus estimate of $369.88 million by 3.17 percent. This is a 23.86 percent increase over sales of $308.10 million the same period last year.

SPX FLOW Q2 EPS From Continuing Operations $0.27 Misses $0.59 Estimate, Sales $381.60M Beat $369.88M Estimate

COWZ December Reconstitution: 21 Substitutions And A Bold Bet On Energy Prices

VFLO: My Balanced Take On Victory Capital's Free Cash Flow Yield ETF

COWZ March Reconstitution: High-Quality Deep Value Play Remains

VFLO: Reconstitution Update, New Factor Mix For This Growing FCF Yield ETF

COWZ June Reconstitution: 29 Substitutions Reshape This $26 Billion Cash Cows ETF

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Everyone&rsquo;s definition of cash-cow stocks is different.



I consider cash-cow stocks to be companies whose free cash flow (FCF) is considerably higher than the capital expenditures required to keep the business running efficiently. FCF generators with high FCF yields, defined as free cash flow divided by enterprise value, are even better.&nbsp;



I look for those with FCF yields above 8%, although they&rsquo;re not that common given today&rsquo;s inflated share prices.&nbsp;



Two ETFs that select the stocks held in their funds using free cash flow yield are the Global X U.S. Cash Flow Kings 100 ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/flow-stock-quote/">FLOW</a>) and the Pacer US Cash Cows 100 ETF (BATS:<a href="https://investorplace.com/stock-quotes/cowz-stock-quote/">COWZ</a>).&nbsp;



To ensure fairness, I&rsquo;ll choose at least one stock from each ETF and ensure that each has a dividend yield of 3% or higher.&nbsp;



Here are my three cash-cow stocks offering unbeatable income.&nbsp;



<h2>Diamondback Energy (FANG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/fang1600e-min-300x169.jpg" alt=""><div>Source: Shutterstock</div></div>Although Diamondback Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/fang-stock-quote/">FANG</a>) is held by both FLOW and COWZ in their top 10 holdings, it is officially a pick from COWZ, where it&rsquo;s the second-largest holding of the ETF, weighted at <a href="https://www.paceretfs.com/products/cowz">2.16%</a>.&nbsp;



The independent oil and gas producer yields 4.54%.



Earlier this year, the Midland, Texas company <a href="https://www.diamondbackenergy.com/news-releases/news-release-details/diamondback-energy-inc-and-endeavor-energy-resources-lp-merge">announced</a> it would acquire Endeavor Energy Resources L.P. for $26 billion in an all-stock transaction. Endeavor shareholders will receive 117.3 million FANG shares and $8 billion in cash. Diamondback shareholders will own 60.5% of the merged entity, with Endeavor shareholders owning 39.5%.&nbsp;



Diamondback shareholders approved the deal on <a href="https://www.diamondbackenergy.com/news-releases/news-release-details/diamondback-energy-inc-receives-stockholder-approval-proposed">April 26</a>. However, the Federal Trade Commission has <a href="https://www.rigzone.com/news/diamondback_endeavor_merger_faces_antitrust_review-01-may-2024-176592-article/">launched</a> an antitrust review of the acquisition by requesting additional information from the company. Given that the FTC <a href="https://boereport.com/2024/05/02/us-ftc-signals-exxon-deal-approval-bars-executive-from-board-seat/">approved</a> a much larger deal between Exxon Mobil (NYSE:<a href="https://investorplace.com/stock-quotes/xom-stock-quote/">XOM</a>) and Pioneer Natural Resources, I can&rsquo;t see the regulator saying no to the deal.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;



When completed, Diamondback would own 838,000 net acres and produce 816,000 barrels of oil equivalent per day.&nbsp;



With significant free cash flow generation, the combined business will easily be able to support a 4.54% dividend yield moving forward.&nbsp;&nbsp;



<h2>Altria Group (MO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/05/altria-mo-stock-1600-300x169.jpg" alt="Altria office sign in Virginia capital city tobacco business closeup by road street"><div>Source: Kristi Blokhin / Shutterstock.com</div></div>Altria Group (NYSE:<a href="https://investorplace.com/stock-quotes/mo-stock-quote/">MO</a>) is the first of two holdings from FLOW. The cigarette company &mdash; its Marlboro brand controls <a href="https://www.investors.com/research/the-income-investor/dividend-stock-altria-mo-stock/">42%</a> of the U.S. domestic cigarette market &mdash; is the ETF&rsquo;s seventh-largest holding at 2.04%. Altria&rsquo;s dividend yield is 8.38%, the <a href="https://finviz.com/screener.ashx?v=161&amp;f=idx_sp500&amp;o=-dividendyield">second-highest</a> in the S&amp;P 500. Altria has been a dividend darling for years.&nbsp;



Unfortunately, given the stagnant nature of the cigarette business, its shares have done little, losing 5.5% over the past five years. Fortunately, however, its five-year annualized total return is 5.49%, thanks to its hefty dividend.



If you treat it like an income investment rather than a capital gains play, you won&rsquo;t be disappointed over the long haul. You might even be surprised by unexpected appreciation due to its move to smokeless products.&nbsp;



On June 21, Altria received FDA (Food and Drug Administration) <a href="https://investor.altria.com/press-releases/news-details/2024/NJOY-Receives-First-FDA-Authorizations-for-Menthol-E-Vapor-Products/default.aspx">approval</a> for its NJOY menthol e-vapor products.&nbsp;&nbsp;




&ldquo;NJOY ACE remains the only pod-based e-vapor product with marketing authorization from the FDA, and now NJOY has the first and only menthol e-vapor products authorized by the FDA to date,&rdquo; stated its June 21 press release.&nbsp;




Altria paid $2.75 billion in June 2023 for NJOY LLC, the cigarette and vaping company. In Q1 2024, it shipped 11.9 million units.&nbsp;



Altria is moving quickly to provide less harmful products. If it can get there, the sky&rsquo;s the limit for MO stock. Just don&rsquo;t expect it to happen, and enjoy the income.&nbsp;



<h2>LyondellBasell Industries (LYB)&nbsp;&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/08/lyb_1600-300x169.jpg" alt="A LyondellBasell production plant in Wesseling, Germany is seen at dusk."><div>Source: Flagmania / Shutterstock.com</div></div>LyondellBasell Industries (NYSE:<a href="https://investorplace.com/stock-quotes/lyb-stock-quote/">LYB</a>) is the second of two holdings from FLOW. At 2.01%, it is the ETF&rsquo;s ninth-largest holding and has a dividend yield of 5.72%.&nbsp;



As stocks go, it&rsquo;s been disappointing, generating a five-year annualized total return of 7.01%. That&rsquo;s somewhat in line with the specialty chemicals industry but significantly less than the 15.16% annualized total return of the SPDR S&amp;P 500 ETF Trust (NYSEARCA:<a href="https://investorplace.com/stock-quotes/spy-stock-quote/">SPY</a>).



In December 2022, I included the specialty chemical company in a list of seven <a href="https://investorplace.com/stock-types/dividend-stocks/">dividend stocks</a> to buy and hold. At the time, LyondellBasell was undergoing <a href="https://investorplace.com/dividend-stocks-to-buy-and-hold/">organizational changes</a> that were projected to generate an additional $750 million in recurring annual EBITDA (earnings before interest, taxes, depreciation and amortization) by 2025.



That hasn&rsquo;t happened.



In Q1 2024, it reported an adjusted EBITDA of $1.06 billion, down from $1.45 billion a year ago. According to S&amp;P Global Market Intelligence, its trailing 12-month EBITDA as of March 31 was $4.66 billion, down from $4.91 billion in 2023 and $6.26 billion in 2022.&nbsp;&nbsp;&nbsp;



The good news: Of the <a href="https://www.marketwatch.com/investing/stock/lyb/analystestimates">26 analysts</a> still covering its stock, 34% rate it a Buy, compared to 28% at the end of 2022.&nbsp;



With an FCF of <a href="https://www.morningstar.com/stocks/xnys/lyb/financials">$2.68 billion</a> and an enterprise value of <a href="https://www.morningstar.com/stocks/xnys/lyb/valuation">$41.14 billion</a>, its FCF yield is 6.5%. Anything between 4% and 8% is fair value, while over 8% is value territory.&nbsp;



Consider it like MO. Income first and capital gains second.&nbsp;



On the date of publication, Will Ashworth did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Will Ashworth has written about investments full-time since 2008. Publications where he&rsquo;s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He particularly enjoys creating model portfolios that stand the test of time. He lives in Halifax, Nova Scotia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/07/3-cash-cow-stocks-offering-unbeatable-income/">3 Cash-Cow Stocks Offering Unbeatable Income</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Comments

Global X Funds Global X U.S. Cash Flow Kings 100 ETF

Notizie

Ultime notizie per Global X Funds Global X U.S. Cash Flow Kings 100 ETF (ARCA:FLOW)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO